

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | auditory receptor cell differentiation (GO:0042491) | 8.59286993 |
| 2 | female gonad development (GO:0008585) | 5.94592557 |
| 3 | righting reflex (GO:0060013) | 5.64730354 |
| 4 | hair cell differentiation (GO:0035315) | 5.62633253 |
| 5 | cytidine deamination (GO:0009972) | 5.56944906 |
| 6 | cytidine metabolic process (GO:0046087) | 5.56944906 |
| 7 | cytidine catabolic process (GO:0006216) | 5.56944906 |
| 8 | inositol phosphate dephosphorylation (GO:0046855) | 5.51381957 |
| 9 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 5.51381957 |
| 10 | inositol phosphate catabolic process (GO:0071545) | 5.46612155 |
| 11 | platelet dense granule organization (GO:0060155) | 5.30610777 |
| 12 | diterpenoid biosynthetic process (GO:0016102) | 5.24865486 |
| 13 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 5.22083149 |
| 14 | pentose metabolic process (GO:0019321) | 5.12803316 |
| 15 | ketone body metabolic process (GO:1902224) | 5.07335950 |
| 16 | inner ear receptor cell differentiation (GO:0060113) | 4.98467782 |
| 17 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.95625536 |
| 18 | glyoxylate metabolic process (GO:0046487) | 4.83756501 |
| 19 | urate metabolic process (GO:0046415) | 4.81069283 |
| 20 | synaptic vesicle exocytosis (GO:0016079) | 4.71321870 |
| 21 | epoxygenase P450 pathway (GO:0019373) | 4.52312469 |
| 22 | protein-chromophore linkage (GO:0018298) | 4.50023897 |
| 23 | regulation of transforming growth factor beta2 production (GO:0032909) | 4.47648118 |
| 24 | negative regulation of hormone metabolic process (GO:0032351) | 4.42795000 |
| 25 | negative regulation of hormone biosynthetic process (GO:0032353) | 4.42795000 |
| 26 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.32222021 |
| 27 | regulation of transmission of nerve impulse (GO:0051969) | 4.31789235 |
| 28 | polyol catabolic process (GO:0046174) | 4.26048648 |
| 29 | signal peptide processing (GO:0006465) | 4.16269240 |
| 30 | regulation of meiosis (GO:0040020) | 4.15950479 |
| 31 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.07028573 |
| 32 | sensory perception of sound (GO:0007605) | 3.93966716 |
| 33 | drug transmembrane transport (GO:0006855) | 3.89388064 |
| 34 | mechanoreceptor differentiation (GO:0042490) | 3.87991920 |
| 35 | sensory perception of mechanical stimulus (GO:0050954) | 3.87891013 |
| 36 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.83857537 |
| 37 | melanosome transport (GO:0032402) | 3.81522183 |
| 38 | regulation of female gonad development (GO:2000194) | 3.80196874 |
| 39 | establishment of protein localization to Golgi (GO:0072600) | 3.68410323 |
| 40 | establishment of melanosome localization (GO:0032401) | 3.65328748 |
| 41 | retinal metabolic process (GO:0042574) | 3.63829009 |
| 42 | protein targeting to Golgi (GO:0000042) | 3.63013145 |
| 43 | pigment granule transport (GO:0051904) | 3.61857534 |
| 44 | protein localization to Golgi apparatus (GO:0034067) | 3.61738980 |
| 45 | drug catabolic process (GO:0042737) | 3.55397166 |
| 46 | cullin deneddylation (GO:0010388) | 3.52312408 |
| 47 | melanosome localization (GO:0032400) | 3.49880206 |
| 48 | inner ear morphogenesis (GO:0042472) | 3.48503169 |
| 49 | establishment of pigment granule localization (GO:0051905) | 3.47223146 |
| 50 | growth hormone receptor signaling pathway (GO:0060396) | 3.46731270 |
| 51 | myoblast migration (GO:0051451) | 3.42805336 |
| 52 | nephron tubule formation (GO:0072079) | 3.42470549 |
| 53 | kynurenine metabolic process (GO:0070189) | 3.41776682 |
| 54 | mitotic chromosome condensation (GO:0007076) | 3.41682843 |
| 55 | phenylpropanoid metabolic process (GO:0009698) | 3.39877265 |
| 56 | terpenoid biosynthetic process (GO:0016114) | 3.39485880 |
| 57 | reflex (GO:0060004) | 3.39319113 |
| 58 | photoreceptor cell maintenance (GO:0045494) | 3.38322742 |
| 59 | estrogen biosynthetic process (GO:0006703) | 3.37768320 |
| 60 | mitotic metaphase plate congression (GO:0007080) | 3.36106021 |
| 61 | melanosome organization (GO:0032438) | 3.33911600 |
| 62 | pigment granule localization (GO:0051875) | 3.33840995 |
| 63 | negative regulation of gluconeogenesis (GO:0045721) | 3.33684632 |
| 64 | metanephric tubule development (GO:0072170) | 3.32766222 |
| 65 | metanephric nephron tubule development (GO:0072234) | 3.32766222 |
| 66 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 3.31973600 |
| 67 | female gamete generation (GO:0007292) | 3.31161039 |
| 68 | anterograde synaptic vesicle transport (GO:0048490) | 3.30337463 |
| 69 | response to phenylpropanoid (GO:0080184) | 3.29078777 |
| 70 | artery smooth muscle contraction (GO:0014824) | 3.24605620 |
| 71 | endocrine pancreas development (GO:0031018) | 3.24482260 |
| 72 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.23202860 |
| 73 | vitamin D metabolic process (GO:0042359) | 3.22306511 |
| 74 | regulation of meiotic cell cycle (GO:0051445) | 3.22131310 |
| 75 | regulation of glucocorticoid metabolic process (GO:0031943) | 3.22085140 |
| 76 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.21582987 |
| 77 | excretion (GO:0007588) | 3.16575447 |
| 78 | regulation of steroid hormone biosynthetic process (GO:0090030) | 3.16036034 |
| 79 | regulation of keratinocyte proliferation (GO:0010837) | 3.15288877 |
| 80 | drug transport (GO:0015893) | 3.14580467 |
| 81 | regulation of acrosome reaction (GO:0060046) | 3.14172823 |
| 82 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.13877724 |
| 83 | oligosaccharide catabolic process (GO:0009313) | 3.13272426 |
| 84 | inositol phosphate-mediated signaling (GO:0048016) | 3.13241910 |
| 85 | regulation of sister chromatid cohesion (GO:0007063) | 3.07917046 |
| 86 | piRNA metabolic process (GO:0034587) | 3.07461794 |
| 87 | indole-containing compound catabolic process (GO:0042436) | 3.07138368 |
| 88 | indolalkylamine catabolic process (GO:0046218) | 3.07138368 |
| 89 | tryptophan catabolic process (GO:0006569) | 3.07138368 |
| 90 | retinal rod cell development (GO:0046548) | 3.07022276 |
| 91 | melanin biosynthetic process (GO:0042438) | 3.06673639 |
| 92 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.06319409 |
| 93 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.06319409 |
| 94 | metanephric nephron epithelium development (GO:0072243) | 3.02858212 |
| 95 | pigment granule organization (GO:0048753) | 3.02436063 |
| 96 | inner ear receptor cell development (GO:0060119) | 3.01697172 |
| 97 | mitotic sister chromatid cohesion (GO:0007064) | 3.01023061 |
| 98 | aromatic amino acid family catabolic process (GO:0009074) | 3.00131643 |
| 99 | protein K11-linked deubiquitination (GO:0035871) | 2.99965015 |
| 100 | protein localization to cilium (GO:0061512) | 2.99937613 |
| 101 | regulation of meiosis I (GO:0060631) | 2.98971130 |
| 102 | cellular response to growth hormone stimulus (GO:0071378) | 2.98803758 |
| 103 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.97438339 |
| 104 | tricarboxylic acid metabolic process (GO:0072350) | 2.95871868 |
| 105 | protein deneddylation (GO:0000338) | 2.94900030 |
| 106 | phasic smooth muscle contraction (GO:0014821) | 2.94843117 |
| 107 | tonic smooth muscle contraction (GO:0014820) | 2.94391074 |
| 108 | regulation of hexokinase activity (GO:1903299) | 2.93984836 |
| 109 | regulation of glucokinase activity (GO:0033131) | 2.93984836 |
| 110 | detection of mechanical stimulus (GO:0050982) | 2.93413234 |
| 111 | type B pancreatic cell development (GO:0003323) | 2.92794856 |
| 112 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.92249078 |
| 113 | L-phenylalanine catabolic process (GO:0006559) | 2.92249078 |
| 114 | histone H2A monoubiquitination (GO:0035518) | 2.92175777 |
| 115 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.92059312 |
| 116 | L-phenylalanine metabolic process (GO:0006558) | 2.92059312 |
| 117 | indolalkylamine metabolic process (GO:0006586) | 2.90748739 |
| 118 | organic cation transport (GO:0015695) | 2.90477914 |
| 119 | developmental pigmentation (GO:0048066) | 2.90359891 |
| 120 | cellular ketone body metabolic process (GO:0046950) | 2.88494442 |
| 121 | nephron epithelium morphogenesis (GO:0072088) | 2.87240723 |
| 122 | nephron tubule morphogenesis (GO:0072078) | 2.87240723 |
| 123 | cranial nerve morphogenesis (GO:0021602) | 2.86495032 |
| 124 | trivalent inorganic anion homeostasis (GO:0072506) | 2.85845375 |
| 125 | phosphate ion homeostasis (GO:0055062) | 2.85845375 |
| 126 | muscle cell migration (GO:0014812) | 2.84966819 |
| 127 | DNA methylation involved in gamete generation (GO:0043046) | 2.84063304 |
| 128 | respiratory chain complex IV assembly (GO:0008535) | 2.83943142 |
| 129 | nephron tubule development (GO:0072080) | 2.83385534 |
| 130 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.82988255 |
| 131 | secondary metabolite biosynthetic process (GO:0044550) | 2.81446749 |
| 132 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.80713517 |
| 133 | behavioral response to nicotine (GO:0035095) | 2.80462896 |
| 134 | synapsis (GO:0007129) | 2.78867596 |
| 135 | aromatic amino acid family metabolic process (GO:0009072) | 2.78525893 |
| 136 | amine catabolic process (GO:0009310) | 2.78136009 |
| 137 | cellular biogenic amine catabolic process (GO:0042402) | 2.78136009 |
| 138 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.76715447 |
| 139 | oxidative demethylation (GO:0070989) | 2.75571506 |
| 140 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.74643865 |
| 141 | neuromuscular process controlling balance (GO:0050885) | 2.74640898 |
| 142 | mannosylation (GO:0097502) | 2.74447644 |
| 143 | axoneme assembly (GO:0035082) | 2.73672619 |
| 144 | male genitalia development (GO:0030539) | 2.73530323 |
| 145 | histone H2A ubiquitination (GO:0033522) | 2.73141990 |
| 146 | endosome to pigment granule transport (GO:0043485) | 2.72179408 |
| 147 | endosome to melanosome transport (GO:0035646) | 2.72179408 |
| 148 | detection of light stimulus involved in visual perception (GO:0050908) | 2.71268407 |
| 149 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.71268407 |
| 150 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.70825342 |
| 151 | early endosome to late endosome transport (GO:0045022) | 2.70175611 |
| 152 | positive regulation of glycolytic process (GO:0045821) | 2.69193489 |
| 153 | positive regulation of neurological system process (GO:0031646) | 2.67858359 |
| 154 | tryptophan metabolic process (GO:0006568) | 2.67241844 |
| 155 | sphingoid metabolic process (GO:0046519) | 2.65693795 |
| 156 | face development (GO:0060324) | 2.65058988 |
| 157 | cell differentiation involved in metanephros development (GO:0072202) | 2.64164343 |
| 158 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.63904349 |
| 159 | phenol-containing compound biosynthetic process (GO:0046189) | 2.61905753 |
| 160 | asymmetric protein localization (GO:0008105) | 2.61645831 |
| 161 | metanephric epithelium development (GO:0072207) | 2.60806677 |
| 162 | generation of neurons (GO:0048699) | 2.60778746 |
| 163 | response to pheromone (GO:0019236) | 2.60606726 |
| 164 | neural tube formation (GO:0001841) | 2.60573119 |
| 165 | negative regulation of chemokine production (GO:0032682) | 2.58105875 |
| 166 | proline transport (GO:0015824) | 2.57333873 |
| 167 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.57312112 |
| 168 | regulation of cardioblast proliferation (GO:0003264) | 2.57312112 |
| 169 | xenobiotic catabolic process (GO:0042178) | 2.57308823 |
| 170 | metaphase plate congression (GO:0051310) | 2.56172461 |
| 171 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.56120135 |
| 172 | male sex determination (GO:0030238) | 2.55408617 |
| 173 | metanephric mesenchyme development (GO:0072075) | 2.55394426 |
| 174 | insulin secretion (GO:0030073) | 2.55184894 |
| 175 | keratinocyte development (GO:0003334) | 2.55003614 |
| 176 | exogenous drug catabolic process (GO:0042738) | 2.54897179 |
| 177 | oocyte development (GO:0048599) | 2.54890041 |
| 178 | regulation of neuron projection regeneration (GO:0070570) | 2.54393784 |
| 179 | regulation of axon regeneration (GO:0048679) | 2.54393784 |
| 180 | cysteine metabolic process (GO:0006534) | 2.52561128 |
| 181 | C-terminal protein amino acid modification (GO:0018410) | 2.51972082 |
| 182 | melanin metabolic process (GO:0006582) | 2.51238318 |
| 183 | multicellular organism reproduction (GO:0032504) | 2.50800401 |
| 184 | phosphorelay signal transduction system (GO:0000160) | 2.50549230 |
| 185 | inositol metabolic process (GO:0006020) | 2.50457905 |
| 186 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.49329824 |
| 187 | magnesium ion transport (GO:0015693) | 2.48605764 |
| 188 | cytochrome complex assembly (GO:0017004) | 2.47578950 |
| 189 | tight junction assembly (GO:0070830) | 2.47483682 |
| 190 | transmission of nerve impulse (GO:0019226) | 2.47298828 |
| 191 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.47233514 |
| 192 | retinal ganglion cell axon guidance (GO:0031290) | 2.46283768 |
| 193 | meiotic cell cycle (GO:0051321) | 2.45657165 |
| 194 | oocyte maturation (GO:0001556) | 2.45058104 |
| 195 | phosphate ion transport (GO:0006817) | 2.44931010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.16810087 |
| 2 | * VDR_22108803_ChIP-Seq_LS180_Human | 3.04007551 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.00020299 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.45022211 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.40083742 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.32987929 |
| 7 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.26228289 |
| 8 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.25259849 |
| 9 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.15649572 |
| 10 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.13845215 |
| 11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.10435835 |
| 12 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.05228788 |
| 13 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.96438534 |
| 14 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.96004826 |
| 15 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.94635320 |
| 16 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.81313966 |
| 17 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.80450057 |
| 18 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.79125947 |
| 19 | FUS_26573619_Chip-Seq_HEK293_Human | 1.78914295 |
| 20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.76578057 |
| 21 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.75304054 |
| 22 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.73253051 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.70838075 |
| 24 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.69670165 |
| 25 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.66830741 |
| 26 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.66549636 |
| 27 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.64455016 |
| 28 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.62488951 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.60861338 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.60861338 |
| 31 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.59999323 |
| 32 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.59999323 |
| 33 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.59239531 |
| 34 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.57546346 |
| 35 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.56399701 |
| 36 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.56399701 |
| 37 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.55941094 |
| 38 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.54822348 |
| 39 | AR_25329375_ChIP-Seq_VCAP_Human | 1.54533872 |
| 40 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.51821382 |
| 41 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.50834317 |
| 42 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.50834317 |
| 43 | TCF4_23295773_ChIP-Seq_U87_Human | 1.50796378 |
| 44 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.49546184 |
| 45 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.48560266 |
| 46 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.48488719 |
| 47 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.45566531 |
| 48 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45109012 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.44812315 |
| 50 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.44179084 |
| 51 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.42285766 |
| 52 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.42252910 |
| 53 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.41994137 |
| 54 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.41284877 |
| 55 | P300_19829295_ChIP-Seq_ESCs_Human | 1.40738051 |
| 56 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.38797487 |
| 57 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.38498012 |
| 58 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.37926522 |
| 59 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37676160 |
| 60 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.37313015 |
| 61 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.37254390 |
| 62 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.36991266 |
| 63 | TP53_16413492_ChIP-PET_HCT116_Human | 1.36805623 |
| 64 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.35864693 |
| 65 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.34476268 |
| 66 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.33721324 |
| 67 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.33588923 |
| 68 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32963787 |
| 69 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.32308791 |
| 70 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.32022473 |
| 71 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.32002294 |
| 72 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.31686854 |
| 73 | STAT3_23295773_ChIP-Seq_U87_Human | 1.31512097 |
| 74 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31460092 |
| 75 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.30823513 |
| 76 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.30579578 |
| 77 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.30087675 |
| 78 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.30026380 |
| 79 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.29603019 |
| 80 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.28826654 |
| 81 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.28760959 |
| 82 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.27733947 |
| 83 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.27351992 |
| 84 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.27261575 |
| 85 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.26899428 |
| 86 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.26388830 |
| 87 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.26353866 |
| 88 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.26227654 |
| 89 | * AR_21909140_ChIP-Seq_LNCAP_Human | 1.26075302 |
| 90 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.25887309 |
| 91 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.25563491 |
| 92 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.25453359 |
| 93 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.25380250 |
| 94 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.24798557 |
| 95 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.24761817 |
| 96 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.24200016 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21787277 |
| 98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21787277 |
| 99 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21563572 |
| 100 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.20753799 |
| 101 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.20522823 |
| 102 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.20264086 |
| 103 | * RXR_22108803_ChIP-Seq_LS180_Human | 1.19946294 |
| 104 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.19870492 |
| 105 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19139853 |
| 106 | NCOR_22424771_ChIP-Seq_293T_Human | 1.18776041 |
| 107 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.18728421 |
| 108 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.17907514 |
| 109 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.17424357 |
| 110 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.17424357 |
| 111 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16831623 |
| 112 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.16738143 |
| 113 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16365103 |
| 114 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.15806036 |
| 115 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.15619738 |
| 116 | CJUN_26792858_Chip-Seq_BT549_Human | 1.15501643 |
| 117 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15481326 |
| 118 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.15326882 |
| 119 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.15252395 |
| 120 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.15230981 |
| 121 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.14502900 |
| 122 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14190146 |
| 123 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.14153327 |
| 124 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.12692610 |
| 125 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12682567 |
| 126 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.12636252 |
| 127 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.12617745 |
| 128 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.12606789 |
| 129 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11954910 |
| 130 | NFYB_21822215_ChIP-Seq_K562_Human | 1.11811003 |
| 131 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.11746575 |
| 132 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11718304 |
| 133 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.10634074 |
| 134 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.10288037 |
| 135 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.09591315 |
| 136 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.09560398 |
| 137 | AR_20517297_ChIP-Seq_VCAP_Human | 1.08640795 |
| 138 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.07671100 |
| 139 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.07470598 |
| 140 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.07455216 |
| 141 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06901684 |
| 142 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.05836024 |
| 143 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05572940 |
| 144 | JUN_21703547_ChIP-Seq_K562_Human | 1.05473563 |
| 145 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05352729 |
| 146 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.05234253 |
| 147 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.05157700 |
| 148 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04862367 |
| 149 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04841349 |
| 150 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04687727 |
| 151 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04071518 |
| 152 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.04032647 |
| 153 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03258543 |
| 154 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03088802 |
| 155 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.02987889 |
| 156 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.02807781 |
| 157 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.01649817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003879_abnormal_hair_cell | 7.47676042 |
| 2 | MP0001485_abnormal_pinna_reflex | 6.95898293 |
| 3 | MP0005377_hearing/vestibular/ear_phenot | 6.47331244 |
| 4 | MP0003878_abnormal_ear_physiology | 6.47331244 |
| 5 | MP0003195_calcinosis | 4.36140587 |
| 6 | MP0000372_irregular_coat_pigmentation | 4.02444005 |
| 7 | MP0002638_abnormal_pupillary_reflex | 3.43552015 |
| 8 | MP0000026_abnormal_inner_ear | 3.27316870 |
| 9 | MP0005248_abnormal_Harderian_gland | 3.05700126 |
| 10 | MP0003011_delayed_dark_adaptation | 3.05696805 |
| 11 | MP0005075_abnormal_melanosome_morpholog | 3.05473190 |
| 12 | MP0002102_abnormal_ear_morphology | 2.99145892 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.81261762 |
| 14 | MP0001963_abnormal_hearing_physiology | 2.77433688 |
| 15 | MP0005360_urolithiasis | 2.60667356 |
| 16 | MP0005083_abnormal_biliary_tract | 2.55518180 |
| 17 | MP0003136_yellow_coat_color | 2.45568344 |
| 18 | MP0001486_abnormal_startle_reflex | 2.37191040 |
| 19 | MP0004742_abnormal_vestibular_system | 2.29296715 |
| 20 | MP0003718_maternal_effect | 2.23689895 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.13739770 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.13238785 |
| 23 | MP0005551_abnormal_eye_electrophysiolog | 2.03278104 |
| 24 | MP0001764_abnormal_homeostasis | 2.03144008 |
| 25 | MP0005365_abnormal_bile_salt | 1.97480406 |
| 26 | MP0002876_abnormal_thyroid_physiology | 1.94523744 |
| 27 | MP0004859_abnormal_synaptic_plasticity | 1.93728177 |
| 28 | MP0005253_abnormal_eye_physiology | 1.86832452 |
| 29 | MP0004043_abnormal_pH_regulation | 1.82542641 |
| 30 | MP0005379_endocrine/exocrine_gland_phen | 1.78845211 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.76597209 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.74967088 |
| 33 | MP0003646_muscle_fatigue | 1.70509519 |
| 34 | MP0001765_abnormal_ion_homeostasis | 1.68355549 |
| 35 | MP0006072_abnormal_retinal_apoptosis | 1.67431515 |
| 36 | MP0005395_other_phenotype | 1.67051690 |
| 37 | MP0003938_abnormal_ear_development | 1.65962441 |
| 38 | MP0004270_analgesia | 1.62839953 |
| 39 | MP0000015_abnormal_ear_pigmentation | 1.60913764 |
| 40 | MP0001905_abnormal_dopamine_level | 1.60514491 |
| 41 | MP0001944_abnormal_pancreas_morphology | 1.56873831 |
| 42 | MP0004019_abnormal_vitamin_homeostasis | 1.56420523 |
| 43 | MP0002090_abnormal_vision | 1.54624296 |
| 44 | MP0002653_abnormal_ependyma_morphology | 1.51754380 |
| 45 | MP0008877_abnormal_DNA_methylation | 1.50746779 |
| 46 | MP0004885_abnormal_endolymph | 1.50378843 |
| 47 | MP0010234_abnormal_vibrissa_follicle | 1.44714435 |
| 48 | MP0005220_abnormal_exocrine_pancreas | 1.42104435 |
| 49 | MP0005451_abnormal_body_composition | 1.41648357 |
| 50 | MP0000371_diluted_coat_color | 1.35580801 |
| 51 | MP0002249_abnormal_larynx_morphology | 1.35040529 |
| 52 | MP0006082_CNS_inflammation | 1.31648909 |
| 53 | MP0006276_abnormal_autonomic_nervous | 1.30744671 |
| 54 | MP0004381_abnormal_hair_follicle | 1.30648531 |
| 55 | MP0005257_abnormal_intraocular_pressure | 1.30328829 |
| 56 | MP0002163_abnormal_gland_morphology | 1.30067574 |
| 57 | MP0002168_other_aberrant_phenotype | 1.29913150 |
| 58 | MP0001324_abnormal_eye_pigmentation | 1.29444721 |
| 59 | MP0003283_abnormal_digestive_organ | 1.26755235 |
| 60 | MP0003943_abnormal_hepatobiliary_system | 1.24204572 |
| 61 | MP0002693_abnormal_pancreas_physiology | 1.22189912 |
| 62 | MP0002938_white_spotting | 1.21123798 |
| 63 | MP0009384_cardiac_valve_regurgitation | 1.20485195 |
| 64 | MP0005171_absent_coat_pigmentation | 1.19085192 |
| 65 | MP0002095_abnormal_skin_pigmentation | 1.19046779 |
| 66 | MP0000427_abnormal_hair_cycle | 1.17927495 |
| 67 | MP0009745_abnormal_behavioral_response | 1.17761428 |
| 68 | MP0009697_abnormal_copulation | 1.17347556 |
| 69 | MP0005646_abnormal_pituitary_gland | 1.14730560 |
| 70 | MP0004134_abnormal_chest_morphology | 1.11522175 |
| 71 | MP0009046_muscle_twitch | 1.07239730 |
| 72 | MP0003868_abnormal_feces_composition | 1.05945349 |
| 73 | MP0003942_abnormal_urinary_system | 1.05387060 |
| 74 | MP0003122_maternal_imprinting | 1.04620856 |
| 75 | MP0005332_abnormal_amino_acid | 1.04430687 |
| 76 | MP0000569_abnormal_digit_pigmentation | 1.02763966 |
| 77 | MP0003941_abnormal_skin_development | 1.00757134 |
| 78 | MP0005084_abnormal_gallbladder_morpholo | 1.00429030 |
| 79 | MP0006292_abnormal_olfactory_placode | 0.99802238 |
| 80 | MP0002822_catalepsy | 0.99503114 |
| 81 | MP0002332_abnormal_exercise_endurance | 0.98332681 |
| 82 | MP0002877_abnormal_melanocyte_morpholog | 0.98131460 |
| 83 | MP0001346_abnormal_lacrimal_gland | 0.97461264 |
| 84 | MP0004924_abnormal_behavior | 0.97164731 |
| 85 | MP0005386_behavior/neurological_phenoty | 0.97164731 |
| 86 | MP0005410_abnormal_fertilization | 0.92808689 |
| 87 | MP0001984_abnormal_olfaction | 0.91913650 |
| 88 | MP0000538_abnormal_urinary_bladder | 0.91799153 |
| 89 | MP0002139_abnormal_hepatobiliary_system | 0.89693239 |
| 90 | MP0001756_abnormal_urination | 0.87977899 |
| 91 | MP0009250_abnormal_appendicular_skeleto | 0.87945008 |
| 92 | MP0000678_abnormal_parathyroid_gland | 0.86116976 |
| 93 | MP0000631_abnormal_neuroendocrine_gland | 0.86017980 |
| 94 | MP0001502_abnormal_circadian_rhythm | 0.85789710 |
| 95 | MP0003123_paternal_imprinting | 0.84862586 |
| 96 | MP0002272_abnormal_nervous_system | 0.84562099 |
| 97 | MP0008775_abnormal_heart_ventricle | 0.84395520 |
| 98 | MP0000534_abnormal_ureter_morphology | 0.82849395 |
| 99 | MP0001119_abnormal_female_reproductive | 0.82192629 |
| 100 | MP0001986_abnormal_taste_sensitivity | 0.80155080 |
| 101 | MP0005636_abnormal_mineral_homeostasis | 0.79209825 |
| 102 | MP0004142_abnormal_muscle_tone | 0.78388105 |
| 103 | MP0002282_abnormal_trachea_morphology | 0.77913624 |
| 104 | MP0002233_abnormal_nose_morphology | 0.77552059 |
| 105 | MP0002184_abnormal_innervation | 0.77260910 |
| 106 | MP0005187_abnormal_penis_morphology | 0.76200475 |
| 107 | MP0005408_hypopigmentation | 0.75705105 |
| 108 | MP0010386_abnormal_urinary_bladder | 0.75244894 |
| 109 | MP0002736_abnormal_nociception_after | 0.74916662 |
| 110 | MP0003699_abnormal_female_reproductive | 0.74799424 |
| 111 | MP0002234_abnormal_pharynx_morphology | 0.74650562 |
| 112 | MP0000013_abnormal_adipose_tissue | 0.73947198 |
| 113 | MP0005195_abnormal_posterior_eye | 0.73946509 |
| 114 | MP0009643_abnormal_urine_homeostasis | 0.73734529 |
| 115 | MP0009053_abnormal_anal_canal | 0.73732212 |
| 116 | MP0002752_abnormal_somatic_nervous | 0.71866734 |
| 117 | MP0003755_abnormal_palate_morphology | 0.71486846 |
| 118 | MP0005647_abnormal_sex_gland | 0.70667880 |
| 119 | MP0002078_abnormal_glucose_homeostasis | 0.69926160 |
| 120 | MP0010329_abnormal_lipoprotein_level | 0.69493665 |
| 121 | MP0004145_abnormal_muscle_electrophysio | 0.68844288 |
| 122 | MP0001666_abnormal_nutrient_absorption | 0.67883514 |
| 123 | MP0003953_abnormal_hormone_level | 0.67198558 |
| 124 | MP0008875_abnormal_xenobiotic_pharmacok | 0.66831920 |
| 125 | MP0003186_abnormal_redox_activity | 0.66730564 |
| 126 | MP0002064_seizures | 0.66539824 |
| 127 | MP0003937_abnormal_limbs/digits/tail_de | 0.66208384 |
| 128 | MP0002572_abnormal_emotion/affect_behav | 0.64927407 |
| 129 | MP0003635_abnormal_synaptic_transmissio | 0.64144933 |
| 130 | MP0010030_abnormal_orbit_morphology | 0.63735251 |
| 131 | MP0002063_abnormal_learning/memory/cond | 0.63431543 |
| 132 | MP0000613_abnormal_salivary_gland | 0.62596789 |
| 133 | MP0003315_abnormal_perineum_morphology | 0.62307155 |
| 134 | MP0000049_abnormal_middle_ear | 0.61220244 |
| 135 | MP0010368_abnormal_lymphatic_system | 0.60226518 |
| 136 | MP0000639_abnormal_adrenal_gland | 0.59902762 |
| 137 | MP0002136_abnormal_kidney_physiology | 0.59516780 |
| 138 | MP0000778_abnormal_nervous_system | 0.57928570 |
| 139 | MP0002116_abnormal_craniofacial_bone | 0.57457458 |
| 140 | MP0002837_dystrophic_cardiac_calcinosis | 0.56605305 |
| 141 | MP0003329_amyloid_beta_deposits | 0.56573429 |
| 142 | MP0002909_abnormal_adrenal_gland | 0.55672265 |
| 143 | MP0002067_abnormal_sensory_capabilities | 0.54464476 |
| 144 | MP0002882_abnormal_neuron_morphology | 0.54206895 |
| 145 | MP0000653_abnormal_sex_gland | 0.54173514 |
| 146 | MP0002734_abnormal_mechanical_nocicepti | 0.53677389 |
| 147 | MP0003252_abnormal_bile_duct | 0.53299596 |
| 148 | MP0002928_abnormal_bile_duct | 0.53091904 |
| 149 | MP0009780_abnormal_chondrocyte_physiolo | 0.51813850 |
| 150 | MP0005645_abnormal_hypothalamus_physiol | 0.51325858 |
| 151 | MP0010678_abnormal_skin_adnexa | 0.51280173 |
| 152 | MP0004264_abnormal_extraembryonic_tissu | 0.51084257 |
| 153 | MP0001968_abnormal_touch/_nociception | 0.50728335 |
| 154 | MP0005197_abnormal_uvea_morphology | 0.50645488 |
| 155 | MP0001286_abnormal_eye_development | 0.50549781 |
| 156 | MP0001340_abnormal_eyelid_morphology | 0.50272169 |
| 157 | MP0003115_abnormal_respiratory_system | 0.49443281 |
| 158 | MP0004484_altered_response_of | 0.48753380 |
| 159 | MP0003880_abnormal_central_pattern | 0.48439433 |
| 160 | MP0002229_neurodegeneration | 0.47969840 |
| 161 | MP0003119_abnormal_digestive_system | 0.46901360 |
| 162 | MP0002115_abnormal_skeleton_extremities | 0.45665790 |
| 163 | MP0003861_abnormal_nervous_system | 0.45317213 |
| 164 | MP0003787_abnormal_imprinting | 0.45232409 |
| 165 | MP0002177_abnormal_outer_ear | 0.44967461 |
| 166 | MP0000462_abnormal_digestive_system | 0.44151672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal auditory evoked potentials (HP:0006958) | 7.41100041 |
| 2 | Tetany (HP:0001281) | 5.28386860 |
| 3 | Congenital stationary night blindness (HP:0007642) | 5.12627659 |
| 4 | Hypomagnesemia (HP:0002917) | 5.03852877 |
| 5 | Abnormal drinking behavior (HP:0030082) | 4.57350384 |
| 6 | Polydipsia (HP:0001959) | 4.57350384 |
| 7 | Hyperuricemia (HP:0002149) | 4.45186701 |
| 8 | Increased purine levels (HP:0004368) | 4.45186701 |
| 9 | Polyuria (HP:0000103) | 4.25797293 |
| 10 | Congenital sensorineural hearing impairment (HP:0008527) | 4.24949790 |
| 11 | Hypoglycemic coma (HP:0001325) | 4.16913139 |
| 12 | Decreased central vision (HP:0007663) | 4.09896922 |
| 13 | Multiple enchondromatosis (HP:0005701) | 3.92195092 |
| 14 | Abnormal urine output (HP:0012590) | 3.90560311 |
| 15 | Arterial tortuosity (HP:0005116) | 3.90135350 |
| 16 | Generalized aminoaciduria (HP:0002909) | 3.82321035 |
| 17 | Shawl scrotum (HP:0000049) | 3.70942782 |
| 18 | Pancreatic cysts (HP:0001737) | 3.69688299 |
| 19 | Abnormality of magnesium homeostasis (HP:0004921) | 3.66749769 |
| 20 | Abnormality of renal excretion (HP:0011036) | 3.66673040 |
| 21 | Metabolic alkalosis (HP:0200114) | 3.65697925 |
| 22 | True hermaphroditism (HP:0010459) | 3.48977692 |
| 23 | Hypothermia (HP:0002045) | 3.47669045 |
| 24 | Male infertility (HP:0003251) | 3.39710057 |
| 25 | Febrile seizures (HP:0002373) | 3.39327213 |
| 26 | Vascular tortuosity (HP:0004948) | 3.37795504 |
| 27 | Abnormality of purine metabolism (HP:0004352) | 3.36705760 |
| 28 | Increased circulating renin level (HP:0000848) | 3.31168991 |
| 29 | Bicornuate uterus (HP:0000813) | 3.24893355 |
| 30 | Hepatic necrosis (HP:0002605) | 3.24323660 |
| 31 | Pancreatic fibrosis (HP:0100732) | 3.22365624 |
| 32 | Gout (HP:0001997) | 3.21700931 |
| 33 | Renal tubular acidosis (HP:0001947) | 3.07805492 |
| 34 | Medial flaring of the eyebrow (HP:0010747) | 3.03614466 |
| 35 | Exostoses (HP:0100777) | 3.03115748 |
| 36 | Abnormality of the renal cortex (HP:0011035) | 3.00160140 |
| 37 | Hypokalemic alkalosis (HP:0001949) | 2.99057618 |
| 38 | Papillary thyroid carcinoma (HP:0002895) | 2.93063840 |
| 39 | Proximal tubulopathy (HP:0000114) | 2.86749070 |
| 40 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.86254074 |
| 41 | Hypoplasia of the fovea (HP:0007750) | 2.86254074 |
| 42 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.79158996 |
| 43 | Gaze-evoked nystagmus (HP:0000640) | 2.77990949 |
| 44 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.77879041 |
| 45 | Lymphangioma (HP:0100764) | 2.76924282 |
| 46 | Hyperaldosteronism (HP:0000859) | 2.76526679 |
| 47 | Lower limb asymmetry (HP:0100559) | 2.73202406 |
| 48 | Aplasia involving bones of the extremities (HP:0009825) | 2.73117360 |
| 49 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.73117360 |
| 50 | Aplasia of the phalanges of the hand (HP:0009802) | 2.73117360 |
| 51 | Oligodactyly (hands) (HP:0001180) | 2.72522637 |
| 52 | Hypercalciuria (HP:0002150) | 2.70622813 |
| 53 | Abnormality of chloride homeostasis (HP:0011422) | 2.70111450 |
| 54 | Midline defect of the nose (HP:0004122) | 2.69515899 |
| 55 | Abnormality of the parathyroid morphology (HP:0011766) | 2.69342609 |
| 56 | Hyperactive renin-angiotensin system (HP:0000841) | 2.65999342 |
| 57 | Type I diabetes mellitus (HP:0100651) | 2.65349819 |
| 58 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.63822764 |
| 59 | Lip pit (HP:0100267) | 2.60196327 |
| 60 | Hepatocellular necrosis (HP:0001404) | 2.59133539 |
| 61 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.58404018 |
| 62 | Nephrogenic diabetes insipidus (HP:0009806) | 2.58160969 |
| 63 | Potter facies (HP:0002009) | 2.57223357 |
| 64 | Facial shape deformation (HP:0011334) | 2.57223357 |
| 65 | Renal cortical cysts (HP:0000803) | 2.56618104 |
| 66 | Renal salt wasting (HP:0000127) | 2.55271549 |
| 67 | Sensory axonal neuropathy (HP:0003390) | 2.53421516 |
| 68 | Ocular albinism (HP:0001107) | 2.52032052 |
| 69 | Abnormal biliary tract physiology (HP:0012439) | 2.51826315 |
| 70 | Bile duct proliferation (HP:0001408) | 2.51826315 |
| 71 | Gait imbalance (HP:0002141) | 2.51514500 |
| 72 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51477246 |
| 73 | Abnormality of macular pigmentation (HP:0008002) | 2.51404535 |
| 74 | Facial hemangioma (HP:0000329) | 2.50366019 |
| 75 | Furrowed tongue (HP:0000221) | 2.48923790 |
| 76 | Congenital primary aphakia (HP:0007707) | 2.46640539 |
| 77 | Abnormality of midbrain morphology (HP:0002418) | 2.46575830 |
| 78 | Molar tooth sign on MRI (HP:0002419) | 2.46575830 |
| 79 | Chronic hepatic failure (HP:0100626) | 2.43584174 |
| 80 | Hyperventilation (HP:0002883) | 2.42769769 |
| 81 | Vitreoretinal degeneration (HP:0000655) | 2.42203188 |
| 82 | Epiphyseal dysplasia (HP:0002656) | 2.42040279 |
| 83 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.40176954 |
| 84 | Iris hypopigmentation (HP:0007730) | 2.39156769 |
| 85 | Attenuation of retinal blood vessels (HP:0007843) | 2.38815880 |
| 86 | Choroideremia (HP:0001139) | 2.38522477 |
| 87 | Abnormality of the fovea (HP:0000493) | 2.36264213 |
| 88 | Intestinal atresia (HP:0011100) | 2.36253879 |
| 89 | Abnormal hair whorl (HP:0010721) | 2.35937543 |
| 90 | Progressive macrocephaly (HP:0004481) | 2.35713263 |
| 91 | Patchy hypopigmentation of hair (HP:0011365) | 2.35296380 |
| 92 | Large for gestational age (HP:0001520) | 2.33661120 |
| 93 | Azoospermia (HP:0000027) | 2.33072233 |
| 94 | Cystic liver disease (HP:0006706) | 2.31522118 |
| 95 | Blue irides (HP:0000635) | 2.30997447 |
| 96 | Glycosuria (HP:0003076) | 2.29208887 |
| 97 | Abnormality of urine glucose concentration (HP:0011016) | 2.29208887 |
| 98 | Spondylolisthesis (HP:0003302) | 2.28801949 |
| 99 | Chin dimple (HP:0010751) | 2.28783394 |
| 100 | Nephronophthisis (HP:0000090) | 2.28502820 |
| 101 | Ketosis (HP:0001946) | 2.28446672 |
| 102 | Oligodactyly (HP:0012165) | 2.28230851 |
| 103 | Hypoglycemic seizures (HP:0002173) | 2.25046780 |
| 104 | Abnormal pancreas size (HP:0012094) | 2.22277747 |
| 105 | Type II lissencephaly (HP:0007260) | 2.21993985 |
| 106 | Tubulointerstitial fibrosis (HP:0005576) | 2.20775639 |
| 107 | Severe Myopia (HP:0011003) | 2.19584756 |
| 108 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.16749138 |
| 109 | Sex reversal (HP:0012245) | 2.16302664 |
| 110 | Abnormal sex determination (HP:0012244) | 2.16302664 |
| 111 | Acute necrotizing encephalopathy (HP:0006965) | 2.15959826 |
| 112 | Sclerocornea (HP:0000647) | 2.15805371 |
| 113 | Delayed epiphyseal ossification (HP:0002663) | 2.13300303 |
| 114 | Disproportionate short-trunk short stature (HP:0003521) | 2.13024319 |
| 115 | Confusion (HP:0001289) | 2.12412189 |
| 116 | Progressive inability to walk (HP:0002505) | 2.12402356 |
| 117 | Type I transferrin isoform profile (HP:0003642) | 2.09496434 |
| 118 | Abnormality of the fingertips (HP:0001211) | 2.09460793 |
| 119 | Acute encephalopathy (HP:0006846) | 2.08954516 |
| 120 | Hydroxyprolinuria (HP:0003080) | 2.08562743 |
| 121 | Abnormality of proline metabolism (HP:0010907) | 2.08562743 |
| 122 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.08463098 |
| 123 | Fibular aplasia (HP:0002990) | 2.07899982 |
| 124 | Abnormality of nucleobase metabolism (HP:0010932) | 2.07504432 |
| 125 | Abnormality of the renal medulla (HP:0100957) | 2.07054404 |
| 126 | Camptodactyly of toe (HP:0001836) | 2.06960181 |
| 127 | Enlarged epiphyses (HP:0010580) | 2.05982261 |
| 128 | Morphological abnormality of the inner ear (HP:0011390) | 2.04319715 |
| 129 | Abnormal cartilage morphology (HP:0002763) | 2.03905079 |
| 130 | Increased CSF lactate (HP:0002490) | 2.02849229 |
| 131 | Mitochondrial inheritance (HP:0001427) | 2.01244696 |
| 132 | Generalized hypopigmentation of hair (HP:0011358) | 2.00063458 |
| 133 | Abnormality of cochlea (HP:0000375) | 1.99819906 |
| 134 | Tubular atrophy (HP:0000092) | 1.97979812 |
| 135 | Nephrocalcinosis (HP:0000121) | 1.96623297 |
| 136 | Hypokinesia (HP:0002375) | 1.94516249 |
| 137 | Diminished movement (HP:0002374) | 1.94340609 |
| 138 | Dyskinesia (HP:0100660) | 1.93073728 |
| 139 | Amblyopia (HP:0000646) | 1.92851400 |
| 140 | Albinism (HP:0001022) | 1.92615716 |
| 141 | Genital tract atresia (HP:0001827) | 1.91818126 |
| 142 | Abnormal albumin level (HP:0012116) | 1.90683834 |
| 143 | Hypoalbuminemia (HP:0003073) | 1.90683834 |
| 144 | Thyroid carcinoma (HP:0002890) | 1.87926452 |
| 145 | Occipital encephalocele (HP:0002085) | 1.87885718 |
| 146 | Generalized hypopigmentation (HP:0007513) | 1.87782654 |
| 147 | Abnormality of the pubic bones (HP:0003172) | 1.86893043 |
| 148 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.86452519 |
| 149 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.86452519 |
| 150 | Abnormality of glycolipid metabolism (HP:0010969) | 1.86452519 |
| 151 | Fair hair (HP:0002286) | 1.86041395 |
| 152 | Mixed hearing impairment (HP:0000410) | 1.85039678 |
| 153 | Patellar aplasia (HP:0006443) | 1.82504890 |
| 154 | Male pseudohermaphroditism (HP:0000037) | 1.82304939 |
| 155 | Apathy (HP:0000741) | 1.81806722 |
| 156 | White forelock (HP:0002211) | 1.81759990 |
| 157 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.81660910 |
| 158 | Severe visual impairment (HP:0001141) | 1.81659341 |
| 159 | Neuroendocrine neoplasm (HP:0100634) | 1.80810800 |
| 160 | Arachnodactyly (HP:0001166) | 1.80738968 |
| 161 | EEG with generalized epileptiform discharges (HP:0011198) | 1.80714165 |
| 162 | Hyperglycemia (HP:0003074) | 1.80024912 |
| 163 | Vaginal atresia (HP:0000148) | 1.79413483 |
| 164 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.79245029 |
| 165 | Epileptiform EEG discharges (HP:0011182) | 1.78676411 |
| 166 | Exocrine pancreatic insufficiency (HP:0001738) | 1.78416164 |
| 167 | Stomach cancer (HP:0012126) | 1.74884944 |
| 168 | Hypophosphatemic rickets (HP:0004912) | 1.74720423 |
| 169 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.72604110 |
| 170 | Neonatal respiratory distress (HP:0002643) | 1.71899678 |
| 171 | Hip contracture (HP:0003273) | 1.71846756 |
| 172 | Abnormality of renin-angiotensin system (HP:0000847) | 1.71833280 |
| 173 | Steatorrhea (HP:0002570) | 1.71305903 |
| 174 | Hypsarrhythmia (HP:0002521) | 1.71282419 |
| 175 | Horizontal nystagmus (HP:0000666) | 1.71254785 |
| 176 | Alkalosis (HP:0001948) | 1.67859663 |
| 177 | Morphological abnormality of the middle ear (HP:0008609) | 1.67271525 |
| 178 | Hyperphosphaturia (HP:0003109) | 1.64508065 |
| 179 | Synostosis of carpal bones (HP:0005048) | 1.64420647 |
| 180 | Epidermoid cyst (HP:0200040) | 1.63141259 |
| 181 | Sandal gap (HP:0001852) | 1.62880746 |
| 182 | Hemangiomatosis (HP:0007461) | 1.61971772 |
| 183 | Asymmetric growth (HP:0100555) | 1.61120480 |
| 184 | Diminished motivation (HP:0000745) | 1.58817517 |
| 185 | Metaphyseal dysplasia (HP:0100255) | 1.58315141 |
| 186 | Hepatoblastoma (HP:0002884) | 1.57857815 |
| 187 | Vacuolated lymphocytes (HP:0001922) | 1.57703365 |
| 188 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.57689448 |
| 189 | Exotropia (HP:0000577) | 1.56831118 |
| 190 | Focal motor seizures (HP:0011153) | 1.54642913 |
| 191 | Ketoacidosis (HP:0001993) | 1.54435364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.38965724 |
| 2 | LATS1 | 4.32042556 |
| 3 | MAP3K9 | 3.31816838 |
| 4 | MST4 | 3.27931105 |
| 5 | KSR2 | 3.22105972 |
| 6 | STK38L | 3.10891538 |
| 7 | WNK4 | 2.92051281 |
| 8 | BMPR2 | 2.87344170 |
| 9 | MOS | 2.81947225 |
| 10 | LATS2 | 2.70532347 |
| 11 | INSRR | 2.56165359 |
| 12 | EEF2K | 2.55051037 |
| 13 | BCR | 2.52295444 |
| 14 | WNK3 | 2.43689170 |
| 15 | MAP3K13 | 2.40163712 |
| 16 | KSR1 | 2.36855918 |
| 17 | ERBB3 | 2.25381327 |
| 18 | EPHA4 | 2.25104807 |
| 19 | ACVR1B | 2.21788614 |
| 20 | PINK1 | 2.19628815 |
| 21 | RAF1 | 2.14704233 |
| 22 | TRPM7 | 2.10843174 |
| 23 | TRIM28 | 2.08240279 |
| 24 | ERBB4 | 2.03689831 |
| 25 | OXSR1 | 2.03409041 |
| 26 | ARAF | 1.93473969 |
| 27 | EPHA3 | 1.91067178 |
| 28 | GRK1 | 1.90922395 |
| 29 | RIPK4 | 1.73662417 |
| 30 | SIK3 | 1.72203264 |
| 31 | DDR2 | 1.71165002 |
| 32 | CASK | 1.66970170 |
| 33 | MAP3K6 | 1.66039863 |
| 34 | BRAF | 1.62840164 |
| 35 | EPHA2 | 1.62156214 |
| 36 | TAOK3 | 1.56334535 |
| 37 | MAP3K3 | 1.53470458 |
| 38 | EIF2AK3 | 1.48291943 |
| 39 | MAP3K12 | 1.44109362 |
| 40 | PRKD3 | 1.43780521 |
| 41 | MAP4K2 | 1.42473377 |
| 42 | ADRBK2 | 1.42169218 |
| 43 | PLK2 | 1.41613337 |
| 44 | MUSK | 1.39773387 |
| 45 | NME1 | 1.39116381 |
| 46 | NUAK1 | 1.39033057 |
| 47 | PIK3CG | 1.37916508 |
| 48 | MAPK13 | 1.27163578 |
| 49 | MELK | 1.25180839 |
| 50 | STK38 | 1.25009739 |
| 51 | DMPK | 1.23441846 |
| 52 | STK24 | 1.18731559 |
| 53 | PAK6 | 1.15292974 |
| 54 | MYLK | 1.14355063 |
| 55 | PAK3 | 1.12904782 |
| 56 | DYRK2 | 1.11510424 |
| 57 | TTK | 1.08949219 |
| 58 | STK39 | 1.05097009 |
| 59 | NEK6 | 1.04540384 |
| 60 | STK3 | 0.99606534 |
| 61 | PLK4 | 0.97476699 |
| 62 | FER | 0.95762027 |
| 63 | NTRK1 | 0.95063986 |
| 64 | SGK2 | 0.94941360 |
| 65 | NTRK3 | 0.92703197 |
| 66 | MAP3K4 | 0.92374619 |
| 67 | TGFBR1 | 0.92341621 |
| 68 | CDC7 | 0.88252816 |
| 69 | RET | 0.88060511 |
| 70 | SGK223 | 0.87607289 |
| 71 | SGK494 | 0.87607289 |
| 72 | FGFR2 | 0.86911313 |
| 73 | HIPK2 | 0.85966144 |
| 74 | PTK2B | 0.85643956 |
| 75 | LIMK1 | 0.84059619 |
| 76 | STK10 | 0.78217139 |
| 77 | EPHB1 | 0.77333636 |
| 78 | MAPKAPK5 | 0.77100940 |
| 79 | FGR | 0.76963671 |
| 80 | CDK9 | 0.75634549 |
| 81 | PRKCG | 0.70801617 |
| 82 | TAOK1 | 0.69076653 |
| 83 | MET | 0.69070581 |
| 84 | CSNK1G2 | 0.68959058 |
| 85 | ADRBK1 | 0.68093464 |
| 86 | PASK | 0.67130805 |
| 87 | MARK3 | 0.65553792 |
| 88 | CSNK1G3 | 0.65192018 |
| 89 | CSNK1G1 | 0.60757995 |
| 90 | EPHB2 | 0.60528305 |
| 91 | PRKD2 | 0.60152965 |
| 92 | TNK2 | 0.59567985 |
| 93 | PRKCE | 0.58743275 |
| 94 | CAMK2A | 0.58075790 |
| 95 | ROCK1 | 0.57558633 |
| 96 | MAPKAPK3 | 0.57537060 |
| 97 | TEC | 0.56284432 |
| 98 | PHKG1 | 0.56122947 |
| 99 | PHKG2 | 0.56122947 |
| 100 | CSNK1A1L | 0.55654158 |
| 101 | CDK8 | 0.55405796 |
| 102 | MINK1 | 0.54520058 |
| 103 | MAP2K4 | 0.53623878 |
| 104 | SGK3 | 0.52924040 |
| 105 | MAP3K2 | 0.52804985 |
| 106 | CAMKK2 | 0.52613145 |
| 107 | PKN1 | 0.52492219 |
| 108 | PRKCI | 0.47130395 |
| 109 | TXK | 0.46604365 |
| 110 | FLT3 | 0.45352141 |
| 111 | TYRO3 | 0.45011278 |
| 112 | MAPK15 | 0.44373521 |
| 113 | DYRK1A | 0.43686766 |
| 114 | CDK5 | 0.42559695 |
| 115 | NLK | 0.42442570 |
| 116 | MAPK11 | 0.42386544 |
| 117 | SGK1 | 0.41789629 |
| 118 | MAP3K1 | 0.41335958 |
| 119 | NEK9 | 0.40953666 |
| 120 | MAP2K1 | 0.40248954 |
| 121 | PRKAA2 | 0.39413344 |
| 122 | BMPR1B | 0.39391589 |
| 123 | MAP2K6 | 0.38703280 |
| 124 | MST1R | 0.38558610 |
| 125 | MKNK2 | 0.38025208 |
| 126 | ERBB2 | 0.37722191 |
| 127 | PRKCZ | 0.37571190 |
| 128 | PRKCH | 0.37182597 |
| 129 | STK11 | 0.36736545 |
| 130 | ROCK2 | 0.35009169 |
| 131 | TNIK | 0.34834588 |
| 132 | MAP3K8 | 0.34741927 |
| 133 | IRAK1 | 0.34484873 |
| 134 | PTK2 | 0.34420730 |
| 135 | PRKACA | 0.34056864 |
| 136 | CSNK1D | 0.33061580 |
| 137 | CDK6 | 0.32291774 |
| 138 | BRSK2 | 0.32283765 |
| 139 | WNK1 | 0.31168472 |
| 140 | MAP2K7 | 0.30799398 |
| 141 | AKT2 | 0.30627431 |
| 142 | DAPK2 | 0.30359278 |
| 143 | ABL2 | 0.29868666 |
| 144 | EGFR | 0.28597206 |
| 145 | NEK1 | 0.28191624 |
| 146 | PRKCQ | 0.27982115 |
| 147 | IKBKB | 0.27725437 |
| 148 | RPS6KB2 | 0.27194171 |
| 149 | PRKAA1 | 0.26743163 |
| 150 | PRKG2 | 0.26729437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 3.29794317 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.93940541 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.67665574 |
| 4 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.61654743 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.57277658 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.32840362 |
| 7 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.12945372 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.05455799 |
| 9 | Phototransduction_Homo sapiens_hsa04744 | 1.95462553 |
| 10 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.95317267 |
| 11 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.95013483 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 1.89930135 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.89778085 |
| 14 | Retinol metabolism_Homo sapiens_hsa00830 | 1.87572299 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.82326552 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.81564987 |
| 17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.61912558 |
| 18 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.61189664 |
| 19 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.60413069 |
| 20 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.59442561 |
| 21 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.59199685 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.58866813 |
| 23 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.57697255 |
| 24 | Basal transcription factors_Homo sapiens_hsa03022 | 1.55858673 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.54592243 |
| 26 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.51146810 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.51125949 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49840191 |
| 29 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.49394381 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.47226467 |
| 31 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.47162783 |
| 32 | Nicotine addiction_Homo sapiens_hsa05033 | 1.43556095 |
| 33 | Tight junction_Homo sapiens_hsa04530 | 1.42774493 |
| 34 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.42256279 |
| 35 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.38343827 |
| 36 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.32781387 |
| 37 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.31615262 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.31250890 |
| 39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.28879157 |
| 40 | Circadian rhythm_Homo sapiens_hsa04710 | 1.28366741 |
| 41 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.26483462 |
| 42 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.22802145 |
| 43 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.22623674 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21434632 |
| 45 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.18070302 |
| 46 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.17923777 |
| 47 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.14110220 |
| 48 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.13538039 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13017327 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.11818482 |
| 51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.11559293 |
| 52 | Endometrial cancer_Homo sapiens_hsa05213 | 1.06948179 |
| 53 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.06499984 |
| 54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.05126973 |
| 55 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.03233671 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 1.02582308 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02187855 |
| 58 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.01860029 |
| 59 | Adherens junction_Homo sapiens_hsa04520 | 1.01793287 |
| 60 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.99358295 |
| 61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98664072 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 0.98454665 |
| 63 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.98444802 |
| 64 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.97616621 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.97055725 |
| 66 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.96920297 |
| 67 | Parkinsons disease_Homo sapiens_hsa05012 | 0.95937484 |
| 68 | Cell cycle_Homo sapiens_hsa04110 | 0.95250786 |
| 69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94436959 |
| 70 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.93100185 |
| 71 | Colorectal cancer_Homo sapiens_hsa05210 | 0.92803140 |
| 72 | Mineral absorption_Homo sapiens_hsa04978 | 0.92668681 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92516074 |
| 74 | Glioma_Homo sapiens_hsa05214 | 0.90865094 |
| 75 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.90617026 |
| 76 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90395875 |
| 77 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.90113111 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88534459 |
| 79 | Olfactory transduction_Homo sapiens_hsa04740 | 0.88088918 |
| 80 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.87883180 |
| 81 | GABAergic synapse_Homo sapiens_hsa04727 | 0.87108581 |
| 82 | Insulin secretion_Homo sapiens_hsa04911 | 0.85666722 |
| 83 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.85289483 |
| 84 | Axon guidance_Homo sapiens_hsa04360 | 0.85081158 |
| 85 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.84617419 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.83282673 |
| 87 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.82984583 |
| 88 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.82477850 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82012835 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.81564686 |
| 91 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.81287014 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80550585 |
| 93 | Lysine degradation_Homo sapiens_hsa00310 | 0.80054806 |
| 94 | Bile secretion_Homo sapiens_hsa04976 | 0.79821645 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.78253685 |
| 96 | Gap junction_Homo sapiens_hsa04540 | 0.77979701 |
| 97 | Renin secretion_Homo sapiens_hsa04924 | 0.76701959 |
| 98 | Cocaine addiction_Homo sapiens_hsa05030 | 0.75687360 |
| 99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.74297312 |
| 100 | Huntingtons disease_Homo sapiens_hsa05016 | 0.72454889 |
| 101 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72428195 |
| 102 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.71895970 |
| 103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.70803289 |
| 104 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70619099 |
| 105 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.70558702 |
| 106 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.69714386 |
| 107 | RNA degradation_Homo sapiens_hsa03018 | 0.69290203 |
| 108 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.69199770 |
| 109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68911388 |
| 110 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.68739691 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68628088 |
| 112 | Morphine addiction_Homo sapiens_hsa05032 | 0.67908509 |
| 113 | Salivary secretion_Homo sapiens_hsa04970 | 0.67841803 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66543204 |
| 115 | Alzheimers disease_Homo sapiens_hsa05010 | 0.65730177 |
| 116 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65477492 |
| 117 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.65393976 |
| 118 | Bladder cancer_Homo sapiens_hsa05219 | 0.65383314 |
| 119 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65326151 |
| 120 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64508747 |
| 121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.64070062 |
| 122 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.63699842 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | 0.62512681 |
| 124 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.62363053 |
| 125 | Prostate cancer_Homo sapiens_hsa05215 | 0.61355027 |
| 126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61243907 |
| 127 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.60996490 |
| 128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60781339 |
| 129 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58965879 |
| 130 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58649412 |
| 131 | RNA polymerase_Homo sapiens_hsa03020 | 0.57991319 |
| 132 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.57845474 |
| 133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57585948 |
| 134 | Focal adhesion_Homo sapiens_hsa04510 | 0.55742541 |
| 135 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.55076914 |
| 136 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55039700 |
| 137 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54946018 |
| 138 | Other glycan degradation_Homo sapiens_hsa00511 | 0.54794299 |
| 139 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54691453 |
| 140 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54089004 |
| 141 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53553251 |
| 142 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.53294972 |
| 143 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.53088200 |
| 144 | Circadian entrainment_Homo sapiens_hsa04713 | 0.52758158 |
| 145 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52585784 |
| 146 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52040186 |
| 147 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51899988 |
| 148 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51309294 |
| 149 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.50687248 |
| 150 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.50194860 |
| 151 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49877063 |
| 152 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49610037 |
| 153 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48658308 |
| 154 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.48141885 |
| 155 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47869555 |
| 156 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47364429 |
| 157 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45978751 |
| 158 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45780951 |
| 159 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45678271 |
| 160 | Taste transduction_Homo sapiens_hsa04742 | 0.45269409 |
| 161 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41493624 |
| 162 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.36620967 |
| 163 | Proteasome_Homo sapiens_hsa03050 | 0.35446969 |
| 164 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.35398480 |
| 165 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.34491193 |
| 166 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33276614 |
| 167 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32546755 |
| 168 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30093142 |
| 169 | Homologous recombination_Homo sapiens_hsa03440 | 0.29366627 |

